New Covid variant JN.1 is on the rise in the US

The Centres for Disease Control and Prevention state that there is no evidence that JN.1 is more severe and that it is unknown if its symptoms are noticeably different from those of other variations.

Image credit -Google

According to the Centers for Disease Control and Prevention (CDC), common symptoms of COVID-19 include fever, chills, coughing, shortness of breath, difficulty breathing, exhaustion, headache, muscle aches, and loss of taste or smell.

Image credit -Google

Most patients have moderate upper respiratory symptoms, which go away in four to five days on average. Individuals afflicted with the novel variation may also report chronic nausea and an appetite reduction.

Image credit -Google

It is noted that sudden difficulties feeling hungry, especially in the presence of other symptoms, may indicate the JN.1 infection. At such times, seeking medical advice is indicated.

Image credit -Google

The JN.1 sub-variant was initially discovered in August in Luxembourg and has now spread to more than 30 nations worldwide.

Image credit -Google

There have been cases of the sub-variant reported from China, the US, Singapore, England, France, and even India.

Image credit -Google

According to data made public by the US Centres for Disease Control and Prevention (CDC), during the two weeks that ended on December 9, HV.1 accounted for approximately 30% of COVID-19 cases in the US.

Image credit -Google

The second-most common strain, JN.1 sub-variant, accounted for about 21% of cases, followed by EG.5

Image credit -Google

There has been a global increase in COVID cases, which many scientists link to the discovery of the JN.1 virus. For example, in recent weeks, China has recorded multiple instances of JN.1.

Image credit -Google

In a similar vein, Singapore reported an astounding 56,000 more cases in a single week three days prior, prompting the Health Ministry to issue a travel and citizen advisory.

Image credit -Google

FOR MORE SUCH STORIES VISIT BREEZYSCROLL